IRIS Accounts Production v25.4.0.155 06204449 Board of Directors 1.5.24 30.4.25 30.4.25 false true false false false true false iso4217:GBP iso4217:USD iso4217:EUR xbrli:shares xbrli:pure utr:tonnes utr:kWh 06204449 2024-04-30 06204449 2025-04-30 06204449 2024-05-01 2025-04-30 06204449 2023-04-30 06204449 2023-05-01 2024-04-30 06204449 2024-04-30 06204449 ns15:EnglandWales 2024-05-01 2025-04-30 06204449 ns14:PoundSterling 2024-05-01 2025-04-30 06204449 ns10:Director1 2024-05-01 2025-04-30 06204449 ns10:PrivateLimitedCompanyLtd 2024-05-01 2025-04-30 06204449 ns10:SmallEntities 2024-05-01 2025-04-30 06204449 ns10:AuditExempt-NoAccountantsReport 2024-05-01 2025-04-30 06204449 ns10:SmallCompaniesRegimeForDirectorsReport 2024-05-01 2025-04-30 06204449 ns10:SmallCompaniesRegimeForAccounts 2024-05-01 2025-04-30 06204449 ns10:FullAccounts 2024-05-01 2025-04-30 06204449 1 2024-05-01 2025-04-30 06204449 ns10:Director2 2024-05-01 2025-04-30 06204449 ns10:RegisteredOffice 2024-05-01 2025-04-30 06204449 ns5:CurrentFinancialInstruments 2025-04-30 06204449 ns5:CurrentFinancialInstruments 2024-04-30 06204449 ns5:ShareCapital 2025-04-30 06204449 ns5:ShareCapital 2024-04-30 06204449 ns5:RetainedEarningsAccumulatedLosses 2025-04-30 06204449 ns5:RetainedEarningsAccumulatedLosses 2024-04-30 06204449 ns5:NetGoodwill 2024-05-01 2025-04-30 06204449 ns5:IntangibleAssetsOtherThanGoodwill 2024-05-01 2025-04-30 06204449 ns5:PlantMachinery 2024-05-01 2025-04-30 06204449 ns5:FurnitureFittings 2024-05-01 2025-04-30 06204449 ns5:ComputerEquipment 2024-05-01 2025-04-30 06204449 ns5:NetGoodwill 2024-04-30 06204449 ns5:NetGoodwill 2025-04-30 06204449 ns5:NetGoodwill 2024-04-30 06204449 ns5:PlantMachinery 2024-04-30 06204449 ns5:FurnitureFittings 2024-04-30 06204449 ns5:ComputerEquipment 2024-04-30 06204449 ns5:PlantMachinery 2025-04-30 06204449 ns5:FurnitureFittings 2025-04-30 06204449 ns5:ComputerEquipment 2025-04-30 06204449 ns5:PlantMachinery 2024-04-30 06204449 ns5:FurnitureFittings 2024-04-30 06204449 ns5:ComputerEquipment 2024-04-30 06204449 ns5:WithinOneYear ns5:CurrentFinancialInstruments 2025-04-30 06204449 ns5:WithinOneYear ns5:CurrentFinancialInstruments 2024-04-30

REGISTERED NUMBER: 06204449 (England and Wales)

UNAUDITED FINANCIAL STATEMENTS FOR THE YEAR ENDED 30TH APRIL 2025

FOR

COOMBE HILL PHARMACY LIMITED

COOMBE HILL PHARMACY LIMITED (REGISTERED NUMBER: 06204449) |

CONTENTS OF THE FINANCIAL STATEMENTS

FOR THE YEAR ENDED 30TH APRIL 2025

Page |

| Company Information | 1 |

| Balance Sheet | 2 |

| Notes to the Financial Statements | 4 |

| COOMBE HILL PHARMACY LIMITED |

COMPANY INFORMATION

FOR THE YEAR ENDED 30TH APRIL 2025

| DIRECTORS: | S G Patel MPS

| Mrs M Patel MPS

| REGISTERED OFFICE: | Cornelius House

| 178-180 Church Road

| Hove

| East Sussex

| BN3 2DJ

| REGISTERED NUMBER: | 06204449 (England and Wales)

| ACCOUNTANTS: | Parkers

| Cornelius House

| 178-180 Church Road

| Hove

| East Sussex

| BN3 2DJ

COOMBE HILL PHARMACY LIMITED (REGISTERED NUMBER: 06204449) |

BALANCE SHEET

30TH APRIL 2025

| 2025 | 2024 |

| Notes | £ | £ | £ | £ |

FIXED ASSETS

Intangible assets | 4 | 50,000 |  | 75,000 |  |

Tangible assets | 5 | 4,123 |  | 5,497 |  |

54,123 |  | 80,497 |  |

CURRENT ASSETS

Stocks | 18,000 |  | 20,000 |  |

Debtors | 6 | 209,733 |  | 186,010 |  |

Cash at bank and in hand | 78,352 |  | 71,103 |  |

306,085 |  | 277,113 |  |

CREDITORS

Amounts falling due within one year | 7 | 170,393 |  | 168,375 |  |

NET CURRENT ASSETS | 135,692 |  | 108,738 |  |

TOTAL ASSETS LESS CURRENT LIABILITIES | 189,815 |  | 189,235 |  |

PROVISIONS FOR LIABILITIES | 783 |  | 1,044 |  |

NET ASSETS | 189,032 |  | 188,191 |  |

CAPITAL AND RESERVES

Called up share capital | 100 |  | 100 |  |

Retained earnings | 188,932 |  | 188,091 |  |

SHAREHOLDERS' FUNDS | 189,032 |  | 188,191 |  |

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 30th April 2025.

The members have not required the company to obtain an audit of its financial statements for the year ended 30th April 2025 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:

(a) | ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and

(b) | preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

COOMBE HILL PHARMACY LIMITED (REGISTERED NUMBER: 06204449) |

BALANCE SHEET - continued

30TH APRIL 2025

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 20th January 2026 and were signed on its behalf by:

S G Patel MPS - Director

COOMBE HILL PHARMACY LIMITED (REGISTERED NUMBER: 06204449) |

NOTES TO THE FINANCIAL STATEMENTS

FOR THE YEAR ENDED 30TH APRIL 2025

1. | STATUTORY INFORMATION

| Coombe Hill Pharmacy Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. | ACCOUNTING POLICIES

| Basis of preparing the financial statements

| These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

| Significant judgements and estimates

| No significant judgements have had to be made by the directors in preparing these financial statements.

| Turnover

| Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

| Goodwill

| Goodwill, being the amount paid in connection with the acquisition of a business in 2007, is being amortised evenly over its estimated useful life of twenty years.

| Intangible assets

| Intangible assets are initially measured at cost. After initial recognition, intangible assets are measured at cost less any accumulated amortisation and any accumulated impairment losses.

| Tangible fixed assets

| Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.

| Plant and machinery | - | 25% on reducing balance

| Fixtures and fittings | - | 25% on reducing balance

| Computer equipment | - | 33% on cost

| Stocks

| Stocks are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items.

| Financial instruments

| The company only enters into basic financial instruments transactions that result in the recognition of financial assets and liabilities like trade and other accounts receivable and payable, loans from banks and other third parties, loans to related parties and investments in non-puttable ordinary shares.

| Financial assets that are measured at cost and amortised cost are assessed at the end of each reporting period for objective evidence of impairment. If objective evidence of impairment is found, an impairment loss is recognised in profit or loss.

COOMBE HILL PHARMACY LIMITED (REGISTERED NUMBER: 06204449) |

NOTES TO THE FINANCIAL STATEMENTS - continued

FOR THE YEAR ENDED 30TH APRIL 2025

2. | ACCOUNTING POLICIES - continued

| Taxation

| Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

| Current or deferred taxation assets and liabilities are not discounted.

| Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

| Deferred tax

| Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

| Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

| Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

| Pension costs and other post-retirement benefits

| The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

| Impairment of non-financial assets

| At each reporting date non-financial assets not carried at fair value, like goodwill and plant, property and equipment, are reviewed to determine whether there is an indication that an asset may be impaired. If there is an indication of possible impairment, the recoverable amount of any asset or group of related assets, which is the higher of value in use and the fair value less cost to sell, is estimated and compared with its carrying amount. If the recoverable amount is lower, the carrying amount of the asset is reduced to its recoverable amount and an impairment loss is recognised immediately in profit or loss.

| Stock is also assessed for impairment at each reporting date. The carrying amount of each item of stock, or group of similar items, is compared with its selling price less costs to complete and sell. If an item of stock or group of similar items is impaired, its carrying amount is reduced to selling price less costs to complete and sell, and an impairment loss is recognised immediately in profit or loss.

3. | EMPLOYEES AND DIRECTORS

| The average number of employees during the year was 7 (2024 - 6 ) .

COOMBE HILL PHARMACY LIMITED (REGISTERED NUMBER: 06204449) |

NOTES TO THE FINANCIAL STATEMENTS - continued

FOR THE YEAR ENDED 30TH APRIL 2025

4. | INTANGIBLE FIXED ASSETS

| Goodwill

£ |

| COST

| At 1st May 2024

| and 30th April 2025 | 500,000 |  |

| AMORTISATION

| At 1st May 2024 | 425,000 |  |

| Amortisation for year | 25,000 |  |

| At 30th April 2025 | 450,000 |  |

| NET BOOK VALUE

| At 30th April 2025 | 50,000 |  |

| At 30th April 2024 | 75,000 |  |

5. | TANGIBLE FIXED ASSETS

| Fixtures |

| Plant and |  | and |  | Computer |

| machinery |  | fittings |  | equipment |  | Totals

£ | £ | £ | £ |

| COST

| At 1st May 2024

| and 30th April 2025 | 3,519 |  | 136,499 |  | 8,796 |  | 148,814 |  |

| DEPRECIATION

| At 1st May 2024 | 3,518 |  | 131,004 |  | 8,795 |  | 143,317 |  |

| Charge for year | - |  | 1,374 |  | - |  | 1,374 |  |

| At 30th April 2025 | 3,518 |  | 132,378 |  | 8,795 |  | 144,691 |  |

| NET BOOK VALUE

| At 30th April 2025 | 1 |  | 4,121 |  | 1 |  | 4,123 |  |

| At 30th April 2024 | 1 |  | 5,495 |  | 1 |  | 5,497 |  |

6. | DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR |

2025 | 2024 |

£ | £ |

| Trade debtors | 196,564 |  | 174,215 |  |

| Other debtors | 13,169 |  | 11,795 |  |

209,733 |  | 186,010 |  |

COOMBE HILL PHARMACY LIMITED (REGISTERED NUMBER: 06204449) |

NOTES TO THE FINANCIAL STATEMENTS - continued

FOR THE YEAR ENDED 30TH APRIL 2025

7. | CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR |

2025 | 2024 |

£ | £ |

| Trade creditors | 95,102 |  | 93,912 |  |

| Taxation and social security | 73,303 |  | 71,854 |  |

| Other creditors | 1,988 |  | 2,609 |  |

170,393 |  | 168,375 |  |